5, 2025 /PRNewswire/ -- Novo Nordisk today announced the filing of 14 new lawsuits to safeguard patients from unsafe and unapproved compounded drugs claiming to contain "semaglutide." The defendants named in these lawsuits employ tactics that deceive patients into believing compounded products have been reviewed and approved by FDA or have equivalent safety or effectiveness as Novo Nordisk's approved semaglutide medicines
Patients often lose 10 lbs in 2 weeks , 15 lbs in 1 month , and 25 lbs within the first few months when following a medically supervised plan
You should feel minimal resistance if the needle is in the subcutaneous layer rather than muscle (which lies deeper)
Common surgical procedures that have caused post-surgical gastroparesis include: Advertisement Gastrointestinal infections can trigger gastroparesis
Each dose level in the titration protocol typically lasts 4 weeks before increasing
Fourth - and most time-sensitive: the FDA published a proposed rule on April 30, 2026 proposing to exclude semaglutide and tirzepatide from the 503B Bulks List, with a public comment period closing June 29, 2026